SPONSOR
SystImmune Inc.
Total Trials
2
Recruiting
2
Phases
Phase 1
Conditions studied: Non Small Cell Lung CancerLung CancerBreast CancerEsophageal CancerSmall Cell Lung CancerNasopharyngeal CancerHead and Neck Squamous Cell CarcinomaProstate AdenocarcinomaOvarian CancerEndometrial Cancer
SystImmune Inc. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Non Small Cell Lung Cancer, Lung Cancer, Breast Cancer, Esophageal Cancer.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — SystImmune Inc.
How many clinical trials has SystImmune Inc. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by SystImmune Inc., of which 2 are actively recruiting participants. These trials cover conditions including Non Small Cell Lung Cancer, Lung Cancer, Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does SystImmune Inc. research focus on?
SystImmune Inc. clinical trials span Non Small Cell Lung Cancer, Lung Cancer, Breast Cancer, Esophageal Cancer, Small Cell Lung Cancer, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a SystImmune Inc. clinical trial?
To participate in a SystImmune Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all SystImmune Inc. trials with current recruitment status updated daily.
Clinical Trials by SystImmune Inc.
NCT05983432 Phase 1
Recruiting
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Non Small Cell Lung Cancer
NCT07080242 Phase 1
Recruiting
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
Small Cell Lung Cancer Metastatic or Locally Advanced
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology